期刊文献+

朗格汉斯组织细胞增生症引起的甲损害 被引量:2

Nail changes in Langerhans cell histiocytosis
下载PDF
导出
摘要 朗格汉斯组织细胞增生症(Langerhans cell histiocytosis,LCH)的皮肤损害较多见,而甲损害则罕见。其临床上可表现为指、趾甲的甲周红斑及肿胀、甲襞破坏、纵向开槽、紫癜样纹、甲下紫癜、甲角化过度、甲下脓疱、甲变形、甲板缺失、甲沟炎、甲剥离、纵形红甲和甲蚀斑。报告1例34岁男性患者,具有尿崩症,突眼,骨损害及皮肤黏膜病变,如:头面部脂溢性皮炎样损害,浸润结节和溃疡斑块,特别是在腋下,外生殖器区域。指甲损害表现为甲周红斑及肿胀、甲分离、甲下紫癜、裂片样出血、纵向开槽及纵形红甲。皮损组织病理检查证实为LCH。成人皮肤弥漫性LCH罕见,误诊率高,确诊应结合组织病理学特征、免疫表型及超微结构检查综合分析,甲损害可能是该病系统病变的征象,但其是否为不良预后的标志却未可知。 Skin lesions occur frequently in Langerhans cell histiocytosis (LCH) whereas nail lesions are rare. Nail lesion, is characterized by various features like paronychial erythema, swelling nail fold destruction, longitudinal grooving, purpuric striae, subungual purpura hyperkeratosis, subungual pustules, deformity, loss of nail plate, paronychia, onycholysis, longitudinal ery- thronychia splinter hemorrhages and pitting of the fingernails and toenails. A 34-year-old male presented with diabetes in- sipidus, exophthalmos and bone defects and mucoeutaneous lesions, including seborrheic dermatitis on the face and scalp, infiltrated nodules and ulcerated plaques, especially in the axillae and anogenital region. Nail changes included paronychial erythema, swelling nail fold destruction, subungual purpura, onycholysis, splinter hemorrhages, longitudinal grooving and longitudi nal erythronychia. The diagnosis of Langerhans cell histiocytosis was made by histopathologic examination of skin biopsies. LCH is rare and easy to be misdiagnosed. The confirmed diagnosis is based on the aggregate analysis of its histological features,nail changes in Langerhans cell histiocytosis may be a possible marker of muhisystem disease. The role of nail lesion as an unfavorable prognostic sign is unclear.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2014年第7期415-418,共4页 Journal of Clinical Dermatology
关键词 朗格汉斯组织细胞增生症 甲损害 Langerhans cell histiocytosis nail lesion
  • 相关文献

参考文献18

  • 1Madrigal-Martrnez-Pereda C, Guerrero-Rodriguez V, Guisado- Moya B. Langerhans cell histiocytosis: literature review and de- scriptive analysis of oral manifestations[J].Med Oral Patol Oral Cir Bucal. 2009. 14(5): 222-228.
  • 2高举,袁粒星.郎格汉斯细胞组织细胞增生症的诊断和治疗[J].实用儿科临床杂志,2006,21(15):1037-1040. 被引量:22
  • 3Mataix J, Betlloch 1. Langerhans cell histiocytosis: an update[J]. G ltal Dennatol Venereol, 2009, 144(2): 119-134.
  • 4Braier J, Chantada G, Rosso D, et al. Langerhans cell histiocy- tosis: retrospective evaluation of 123 patients at a single institu- tion[J]. Pediatr Hematol Oncol, 1999, 16(5): 377-385.
  • 5Modtam Moses D, Weintraub M, Meyerovitch J, et al. Hypopitu- itarism in I,angerhans cell histiocytosis: seven Cases and litera- ture review[J]. J Endocrinol Invest, 2001, 24(8): 612-617.
  • 6Yazc N, Yalc'n B, Ciftci AO. Langerhans cell histiocytosis with involvement of nails and lungs in an adolescent [J]. J Pediatr Hematol Oncol, 2008, 30(1): 77-80.
  • 7Rivera-Luna R, Martinez-Gurra F, Ahamirano-Alvarez E, et al. Langerhans'cell histiocytosis:clinical experience with 124 patients[J].Paediatr Dermatol, 1988, 5(3): 145-150.
  • 8Bender B, Holtzman IN. Hisliocytosis-X (granulomatous reticu- Ioendotheliosis)[J]. Arch Dermalol, 1958, 78(6): 692-702.
  • 9de Berker D, Lever I.R, Windebank K. Nail features in Langer- hans cell hisliocytosis[J]. Br J Dermatol 1994, 130(4): 523-527.
  • 10Javier Mataix, Isabel Betlloch, Ana Lacas-Costa, et al. Nail changes is Langerhans cell histiocytosis: a possible marker of mul- tisystem disease[J]. Pediatric Pennatology, 2008, 25(2): 247-251.

二级参考文献19

  • 1Writing Group of Histiocyte Society. Histiocytosis syndromes in children[J]. Lancet, 1987,1:208 - 209.
  • 2Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders, the WHO committee on histiocytic/reticulum cell proliferation.Reclassification Working Group of the Histiocyte Society[J]. Med Pediatr Oncol,1997 , 29 :15 7 - 166.
  • 3Nicholson HS, Egeler RM, Nesbit ME. The epidemiology of Langerhans cell histiocytosis[J]. Hernatol Oncol Clin North Am, 1998, 12(2) : 379 - 384.
  • 4Jaffe R. The histiocytosis [ J ]. Clin Lab Med, 1999,19 ( 1 ) : 135 - 155.
  • 5Egeler RiM, Favara BE, van Meurs M, et al. Differential in situ cytokine profiles of langerhans - like cells and T - cells in langerhans cell histiccytosis: Abundant expression of cytokines relevant to cisease and treatment [ J ]. Blood, 1999,94 : 4195 - 4201.
  • 6Larnan JD, Leenen PJM,Annels NE, et al. Langerhans - cell histiocytosis' insight into DC biology[J]. Trend Immunobiol,2003,24(4):190- 196.
  • 7Yu RC, Chu C, Buluwela L, et al. Clonal proliferation of Langerhans cell in Langerhans cell histiocytosis[ J ]. Lancet, 1994 ; 343 : 767 - 768.
  • 8William CL, Busque L, Giffith BB, et al. Langerhans cell histiocytosis (Histiocytosis X ): A clonal proliferative disease [ J ]. N Engl J Med, 1994,331 : 154 - 160.
  • 9Arico M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis[ J ]. Hernatol Oncol Clin North Am, 1998,12 ( 2 ) : 247 - 257.
  • 10高举,袁粒星.郎格汉斯细胞组织细胞增生症.见:符仁义,刘玉峰.儿童血液与肿瘤疾病[M].郑州:河南科学技术出版社,2005:414—426.

共引文献21

同被引文献8

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部